These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36633929)

  • 21. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity.
    Cheng Y; Ji Y
    J Control Release; 2020 Feb; 318():38-49. PubMed ID: 31830542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo.
    Duan XC; Yao X; Zhang S; Xu MQ; Hao YL; Li ZT; Zheng XC; Liu M; Li ZY; Li H; Wang JR; Feng ZH; Zhang X
    Int J Nanomedicine; 2019; 14():195-204. PubMed ID: 30636872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
    Yang X; Shi X; Ji J; Zhai G
    Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
    Dalela M; Shrivastav TG; Kharbanda S; Singh H
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
    Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
    Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates.
    Guo T; Zhong H; Li X; Mu J; Liu T; Yu N; Zhao Y; Liang XJ; Guo S
    J Control Release; 2023 Jul; 359():175-187. PubMed ID: 37271184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel.
    Zhou K; Zhu Y; Chen X; Li L; Xu W
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111006. PubMed ID: 32993973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.
    Sang M; Zhang Z; Liu F; Hu L; Li L; Chen L; Feng F; Liu W; Qu W
    J Biomed Nanotechnol; 2018 Mar; 14(3):477-495. PubMed ID: 29663921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Versatile redox-sensitive pullulan nanoparticles for enhanced liver targeting and efficient cancer therapy.
    Huang L; Chaurasiya B; Wu D; Wang H; Du Y; Tu J; Webster TJ; Sun C
    Nanomedicine; 2018 Apr; 14(3):1005-1017. PubMed ID: 29409820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CD44-positive ovarian cancers via engineered paclitaxel prodrug nanoparticles for enhanced chemotherapeutic efficacy.
    Sun X; Zhao R; Zhao E; Wang Q; Lian W; Xiong J
    Biomed Pharmacother; 2022 Oct; 154():113655. PubMed ID: 36942600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RGD-decorated redox-responsive d-α-tocopherol polyethylene glycol succinate-poly(lactide) nanoparticles for targeted drug delivery.
    Guo Y; Niu B; Song Q; Zhao Y; Bao Y; Tan S; Si L; Zhang Z
    J Mater Chem B; 2016 Apr; 4(13):2338-2350. PubMed ID: 32263229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted paclitaxel prodrug nanoassemblies to improve therapeutic effects for liver cancer.
    Qin S; Li J; Pan Z; Wang C; Zhang BF
    Colloids Surf B Biointerfaces; 2023 Jun; 226():113285. PubMed ID: 37028229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the cytotoxic effects, cellular uptake and cellular distribution of paclitaxel-loaded nanoparticles in glioblastoma cells
    Wang L; Liu C; Qiao F; Li M; Xin H; Chen N; Wu Y; Liu J
    Exp Ther Med; 2021 Apr; 21(4):292. PubMed ID: 33717235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.